Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Jazz Pharmaceuticals	JAZZ	Healthcare \| Biotechnology	89	11.5%

Current Price (02/26)			$168.04
CAPS Rating (Rate this stock on CAPS)

Expected Income Statement
Current Sales			2,279.8
Sales Growth Forecast			12.1%
Net Profit Margin			42.7%

Projected Shares Outstanding			65.44
EPS - Five year Forecast			$26.36
Average P/E Ratio			11.0
Projected Average Price			$289.97

Price Appreciation (Annualized)			11.5%
Annual Dividend Yield			0.0%
Projected Annual Return			11.5%

Quality
Financial Strength			83	20.7
EPS Stability			97	24.3
Industry Sales Growth Rate			17.0%	8.9
Industry Net Profit Margin			34.0%	15.7
Calculated Quality Rating			69.6

Fool CAPS
Total Players 287 Outperforms 67 Underperforms All-Stars (60) 52 Outperforms (87%) 8 Underperforms

Fundamental Data Updated: 01/08/2021

MIPAR	5.7%
Sweet Spot	10.7% - 15.7%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 10.7%-15.7%
Yellow	PAR is above the target range of MIPAR +10%, currently 15.7%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.